{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:45:37Z","timestamp":1791895537027,"version":"4.3.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jaad.2020.07.042","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:55:50Z","timestamp":1594950950000},"page":"41-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Risk of new-onset inflammatory bowel disease among patients with acne vulgaris exposed to isotretinoin"],"prefix":"10.1016","volume":"84","author":[{"given":"Shari","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jaad.2020.07.042_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4240\/wjgs.v6.i7.142","article-title":"Isotretinoin and ulcerative colitis: a case report and review of the literature","volume":"6","author":"Papaconstantinos","year":"2014","journal-title":"World J Gastrointest Surg"},{"issue":"10","key":"10.1016\/j.jaad.2020.07.042_bib2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1345\/aph.10368","article-title":"Isotretinoin-induced inflammatory bowel disease in an adolescent","volume":"35","author":"Reniers","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.jaad.2020.07.042_bib3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/MCG.0b013e318033df5d","article-title":"Isotretinoin-associated pan-enteritis","volume":"42","author":"Spada","year":"2008","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.jaad.2020.07.042_bib4","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/ajg.2010.124","article-title":"Isotretinoin use and the risk of inflammatory bowel disease: a case-control study","volume":"105","author":"Crockett","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.042_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2014.8","article-title":"Isotretinoin and risk of inflammatory bowel disease: a French nationwide study","volume":"109","author":"Racine","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jaad.2020.07.042_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jamadermatol.2013.1344","article-title":"Isotretinoin and risk for inflammatory bowel disease a nested case-control study and meta-analysis of published and unpublished data","volume":"149","author":"Etminan","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2020.07.042_bib7","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1038\/ajg.2009.417","article-title":"Isotretinoin is not associated with inflammatory bowel disease: a population based case-control study","volume":"104","author":"Bernstein","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.042_bib8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/jid.2012.387","article-title":"Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study","volume":"133","author":"Alhusayen","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2020.07.042_bib9","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jamadermatol.2014.1540","article-title":"Isotretinoin exposure and risk of inflammatory bowel disease","volume":"150","author":"Rashtak","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.042_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1373\/49.4.624","article-title":"LOINC, a universal standard for identifying laboratory observations: a 5-year update","volume":"49","author":"McDonald","year":"2003","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.042_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","article-title":"Normalized names for clinical drugs: RxNorm at 6 years","volume":"18","author":"Nelson","year":"2011","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.jaad.2020.07.042_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2015.12.032","article-title":"Identifying Chinese herbal medicine network for treating acne: implications from a nationwide database","volume":"179","author":"Chen","year":"2016","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"10.1016\/j.jaad.2020.07.042_bib15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/ced.13919","article-title":"The mental health burden in acne vulgaris and rosacea: an analysis of the US National Inpatient Sample","volume":"44","author":"Singam","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2020.07.042_bib16","first-page":"504279","article-title":"Female gender and acne disease are jointly and independently associated with the risk of major depression and suicide: a national population-based study","volume":"2014","author":"Yang","year":"2014","journal-title":"Biomed Res Int"},{"issue":"10","key":"10.1016\/j.jaad.2020.07.042_bib17","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1007\/s10620-014-3174-7","article-title":"Accuracy of diagnostic codes for identifying patients with ulcerative colitis and Crohn's disease in the Veterans Affair Health Care System","volume":"59","author":"Hou","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.jaad.2020.07.042_bib18","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1007\/s10620-009-1074-z","article-title":"Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans","volume":"55","author":"Thirumurthi","year":"2010","journal-title":"Dig Sis Sci"},{"issue":"12","key":"10.1016\/j.jaad.2020.07.042_bib19","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1038\/ajg.2010.303","article-title":"Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease","volume":"105","author":"Margolis","year":"2010","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220322118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220322118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:58:15Z","timestamp":1759273095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220322118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0190962220322118"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.07.042","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738356002.793578552","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of new-onset inflammatory bowel disease among patients with acne vulgaris exposed to isotretinoin","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}